UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
UTAH MEDICAL PRODUCTS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$74.55+0.04 (+0.05%)
Close on Oct 19, 2026
- Market cap
- $237.37M
- P/E (TTM)
- 22.7
- Dividend yield
- –
UTAH MEDICAL PRODUCTS INC revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gynecology/Electrosurgery/Urology | $4.28M | $5.23M | – | $4.95M | $4.81M | $4.90M | – | – | $5.37M | $5.92M | $5.59M | – | 50.2% | -11.0% |
| Neonatal | $1.92M | $1.57M | – | $2.18M | $2.10M | $1.98M | – | – | $1.88M | $1.40M | $1.76M | – | 22.5% | -8.7% |
| Blood Pressure Monitoring and Accessories | $1.26M | $1.02M | – | $1.64M | $2.02M | $1.81M | – | – | $3.83M | $4.48M | $4.15M | – | 14.8% | -37.4% |
| Obstetrics | $1.07M | $905.00K | – | $1.04M | $1.03M | $1.03M | – | – | $1.42M | $1.08M | $1.02M | – | 12.5% | +4.0% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DomesticUsMember | $5.17M | $5.56M | – | $5.86M | $5.87M | $5.58M | – | – | $7.27M | $7.02M | $7.19M | – | 60.6% | -11.9% |
| OutsideUsMember | $3.36M | $3.16M | – | $3.95M | $4.09M | $4.13M | – | – | $5.24M | $5.85M | $5.34M | – | 39.4% | -17.7% |
From the segment and revenue-disaggregation notes of Utah Medical Products's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.